Literature DB >> 20686027

Long-term restriction by APOBEC3F selects human immunodeficiency virus type 1 variants with restored Vif function.

John S Albin1, Guylaine Haché, Judd F Hultquist, William L Brown, Reuben S Harris.   

Abstract

Tandem stop mutations K26X and H27X in human immunodeficiency virus type 1 (HIV-1) vif compromise virus replication in human T-cell lines that stably express APOBEC3F (A3F) or APOBEC3G (A3G). We previously reported that partial resistance to A3G could develop in these Vif-deficient viruses through a nucleotide A200-to-T/C transversion and a vpr null mutation, but these isolates were still susceptible to restriction by A3F. Here, long-term selection experiments were done to determine how these A3G-selected isolates might evolve to spread in the presence of A3F. We found that A3F, like A3G, is capable of potent, long-term restriction that eventually selects for heritable resistance. In all 7 instances, the selected isolates had restored Vif function to cope with A3F activity. In two isolates, Vif Q26-Q27 and Y26-Q27, the resistance phenotype recapitulated in molecular clones, but when the selected vif alleles were analyzed in the context of an otherwise wild-type viral background, a different outcome emerged. Although HIV-1 clones with Vif Q26-Q27 or Y26-Q27 were fully capable of overcoming A3F, they were now susceptible to restriction by A3G. Concordant with prior studies, a lysine at position 26 proved essential for A3G neutralization. These data combine to indicate that A3F and A3G exert at least partly distinct selective pressures and that Vif function may be essential for the virus to replicate in the presence of A3F.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20686027      PMCID: PMC2937771          DOI: 10.1128/JVI.00632-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.

Authors:  Xianghui Yu; Yunkai Yu; Bindong Liu; Kun Luo; Wei Kong; Panyong Mao; Xiao-Fang Yu
Journal:  Science       Date:  2003-10-16       Impact factor: 47.728

2.  Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation.

Authors:  Andrew Mehle; Joao Goncalves; Mariana Santa-Marta; Mark McPike; Dana Gabuzda
Journal:  Genes Dev       Date:  2004-12-01       Impact factor: 11.361

3.  APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms.

Authors:  Jean L Mbisa; Wei Bu; Vinay K Pathak
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

4.  Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsid.

Authors:  David Derse; Shawn A Hill; Gerald Princler; Patricia Lloyd; Gisela Heidecker
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-13       Impact factor: 11.205

5.  A new reporter cell line to monitor HIV infection and drug susceptibility in vitro.

Authors:  A Gervaix; D West; L M Leoni; D D Richman; F Wong-Staal; J Corbeil
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

6.  A transitional endogenous lentivirus from the genome of a basal primate and implications for lentivirus evolution.

Authors:  Robert J Gifford; Aris Katzourakis; Michael Tristem; Oliver G Pybus; Mark Winters; Robert W Shafer
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

7.  Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction.

Authors:  Eric W Refsland; Mark D Stenglein; Keisuke Shindo; John S Albin; William L Brown; Reuben S Harris
Journal:  Nucleic Acids Res       Date:  2010-03-22       Impact factor: 16.971

8.  A patch of positively charged amino acids surrounding the human immunodeficiency virus type 1 Vif SLVx4Yx9Y motif influences its interaction with APOBEC3G.

Authors:  Gongying Chen; Zhiwen He; Tao Wang; Rongzhen Xu; Xiao-Fang Yu
Journal:  J Virol       Date:  2009-06-17       Impact factor: 5.103

9.  Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960.

Authors:  Michael Worobey; Marlea Gemmel; Dirk E Teuwen; Tamara Haselkorn; Kevin Kunstman; Michael Bunce; Jean-Jacques Muyembe; Jean-Marie M Kabongo; Raphaël M Kalengayi; Eric Van Marck; M Thomas P Gilbert; Steven M Wolinsky
Journal:  Nature       Date:  2008-10-02       Impact factor: 49.962

10.  Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity.

Authors:  Gang Peng; Ke Jian Lei; Wenwen Jin; Teresa Greenwell-Wild; Sharon M Wahl
Journal:  J Exp Med       Date:  2006-01-17       Impact factor: 14.307

View more
  34 in total

1.  A single amino acid in human APOBEC3F alters susceptibility to HIV-1 Vif.

Authors:  John S Albin; Rebecca S LaRue; Jessalyn A Weaver; William L Brown; Keisuke Shindo; Elena Harjes; Hiroshi Matsuo; Reuben S Harris
Journal:  J Biol Chem       Date:  2010-10-22       Impact factor: 5.157

2.  Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1.

Authors:  Judd F Hultquist; Joy A Lengyel; Eric W Refsland; Rebecca S LaRue; Lela Lackey; William L Brown; Reuben S Harris
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

Review 3.  Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all.

Authors:  Belete A Desimmie; Krista A Delviks-Frankenberrry; Ryan C Burdick; DongFei Qi; Taisuke Izumi; Vinay K Pathak
Journal:  J Mol Biol       Date:  2013-11-02       Impact factor: 5.469

Review 4.  The restriction factors of human immunodeficiency virus.

Authors:  Reuben S Harris; Judd F Hultquist; David T Evans
Journal:  J Biol Chem       Date:  2012-10-05       Impact factor: 5.157

5.  Catalytic activity of APOBEC3F is required for efficient restriction of Vif-deficient human immunodeficiency virus.

Authors:  John S Albin; William L Brown; Reuben S Harris
Journal:  Virology       Date:  2013-12-20       Impact factor: 3.616

6.  APOBEC3F determinants of HIV-1 Vif sensitivity.

Authors:  Allison M Land; Nadine M Shaban; Leah Evans; Judd F Hultquist; John S Albin; Reuben S Harris
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

7.  Defining HIV-1 Vif residues that interact with CBFβ by site-directed mutagenesis.

Authors:  Yusuke Matsui; Keisuke Shindo; Kayoko Nagata; Katsuhiro Io; Kohei Tada; Fumie Iwai; Masayuki Kobayashi; Norimitsu Kadowaki; Reuben S Harris; Akifumi Takaori-Kondo
Journal:  Virology       Date:  2013-11-26       Impact factor: 3.616

8.  Dispersed sites of HIV Vif-dependent polyubiquitination in the DNA deaminase APOBEC3F.

Authors:  John S Albin; John S Anderson; Jeffrey R Johnson; Elena Harjes; Hiroshi Matsuo; Nevan J Krogan; Reuben S Harris
Journal:  J Mol Biol       Date:  2013-01-11       Impact factor: 5.469

9.  APOBEC3 multimerization correlates with HIV-1 packaging and restriction activity in living cells.

Authors:  Jinhui Li; Yan Chen; Ming Li; Michael A Carpenter; Rebecca M McDougle; Elizabeth M Luengas; Patrick J Macdonald; Reuben S Harris; Joachim D Mueller
Journal:  J Mol Biol       Date:  2013-12-17       Impact factor: 5.469

10.  Crystal structure of the DNA cytosine deaminase APOBEC3F: the catalytically active and HIV-1 Vif-binding domain.

Authors:  Markus-Frederik Bohn; Shivender M D Shandilya; John S Albin; Takahide Kouno; Brett D Anderson; Rebecca M McDougle; Michael A Carpenter; Anurag Rathore; Leah Evans; Ahkillah N Davis; Jingying Zhang; Yongjian Lu; Mohan Somasundaran; Hiroshi Matsuo; Reuben S Harris; Celia A Schiffer
Journal:  Structure       Date:  2013-05-16       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.